Gossamer Bio Inc. (NASDAQ:GOSS) is one of the best biotech stocks to invest in now. On June 16, Gossamer Bio announced the ...

Gossamer Bio Inc. Annual stock financials by MarketWatch. View the latest GOSS financial statements, income statements and financial ratios.

A lush visual palette awaits viewers to the exhibition “Gossamer” from Saturday, June 28 through Saturday, July 26 at the ...

Gossamer Bio (GOSS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Gossamer Bio and the Chiesi Group are jointly developing seralutinib under a global collaboration agreement. "I am incredibly proud to announce that, following the recent closing of new patient ...

Gossamer’s management team will host a conference call and live audio webcast at 4:30 p.m. ET today, Thursday, May 15 th, to discuss its first quarter 2025 financial results and business update.